Chronically-infected HCV Genotype 2 and 3 Treatment-naive Subjects: Part A: Safety and Efficacy of INX-08189 With Peg IFN Alfa-2a and Ribavirin. Part B: INX-08189 in Interferon Free Treatment With Daclatasvir and/or Ribavirin

Name: Chronically-infected HCV Genotype 2 and 3 Treatment-naive Subjects: Part A: Safety and Efficacy of INX-08189 With Peg IFN Alfa-2a and Ribavirin. Part B: INX-08189 in Interferon Free Treatment With Daclatasvir and/or Ribavirin
Published: 2012
License: Public Domain

Bristol-Myers Squibb · 2012

ClinicalTrials.gov · Datasets · License: Public Domain · 2012

Open Source ↗

hepatitis-c hepatitis-c-virus

hepatitis c, inhibitex, chronic hepatitis, hepatitis c virus, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Chronically-infected HCV Genotype 2 and 3 Treatment-naive Subjects: Part A: Safety and Efficacy of INX-08189 With Peg IFN Alfa-2a and Ribavirin. Part B: INX-08189 in Interferon Free Treatment With Daclatasvir and/or Ribavirin

Related documents